Corcept Therapeutics Incorporated. (CORT)

11.96
0.03 0.25
NASDAQ
Prev Close 11.93
Open 11.85
Day Low/High 11.74 / 12.16
52 Wk Low/High 9.14 / 20.00
Volume 656.34K
Exchange NASDAQ
Shares Outstanding 114.72B
Market Cap 1.37B
Div & Yield N.A. (N.A)

Latest News

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Corcept Therapeutics Incorporated To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Corcept Therapeutics Incorporated ("Corcept" or the "Company")(NASDAQ:CORT) of the May 13, 2019 deadline to seek the role of lead plaintiff in a federal securities class...

INVESTOR ALERT: Kirby McInerney LLP Announces The Filing Of A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated

INVESTOR ALERT: Kirby McInerney LLP Announces The Filing Of A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated -- CORT

NEW YORK, March 21, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Corcept Therapeutics Incorporated (NASDAQ: CORT) from August 2, 2017...

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated

Federman & Sherwood Announces Filing Of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated

Federman & Sherwood announces that on March 14, 2019, a class action lawsuit was filed in the United States District Court for the Northern District of California against Corcept Therapeutics Incorporated (NASDAQ: CORT).

CORT Class Action Alert: Hagens Berman Alerts Corcept Therapeutics (NASDAQ: CORT) Investors To Securities Class Action And May 13, 2019 Lead Plaintiff Deadline

CORT Class Action Alert: Hagens Berman Alerts Corcept Therapeutics (NASDAQ: CORT) Investors To Securities Class Action And May 13, 2019 Lead Plaintiff Deadline

SAN FRANCISCO, March 19, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Corcept Therapeutics Incorporated (NASDAQ: CORT) to the May 13, 2019 Lead Plaintiff deadline in the securities class action pending in the United States...

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Corcept Therapeutics Incorporated And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces The Filing Of A Class Action Lawsuit Against Corcept Therapeutics Incorporated And Encourages Investors With Losses In Excess Of $100,000 To Contact The Firm

The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Corcept Therapeutics Incorporated ("Corcept" or "the Company") (NASDAQ: CORT) for violations of §§10(b) and 20(a) of the Securities...

Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

NEW YORK, March 18, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of those who purchased or acquired the securities of Corcept...

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Corcept Therapeutics Incorporated Investors

INVESTOR ALERT: Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Corcept Therapeutics Incorporated Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT) securities between August 2, 2017 and February 5, 2019,...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Corcept Therapeutics Incorporated - CORT

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Corcept Therapeutics Incorporated - CORT

NEW YORK, March 15, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Corcept Therapeutics Incorporated ("Corcept" or the "Company") (NASDAQ: CORT).

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Corcept Therapeutics Incorporated (NASDAQ:CORT) from August 2, 2017 through February 5, 2019, inclusive (the...

Glancy Prongay & Murray LLP Files A Securities Class Action On Behalf Of Corcept Therapeutics Incorporated Investors (CORT)

Glancy Prongay & Murray LLP Files A Securities Class Action On Behalf Of Corcept Therapeutics Incorporated Investors (CORT)

Glancy Prongay & Murray LLP ("GPM") announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Melucci v.

Investor Alert: Kaplan Fox Investigates Corcept Therapeutics Incorporated

Investor Alert: Kaplan Fox Investigates Corcept Therapeutics Incorporated

NEW YORK, Feb. 5, 2019 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP ( www.

Interesting CORT Put And Call Options For August 16th

Interesting CORT Put And Call Options For August 16th

Investors in Corcept Therapeutics Inc saw new options become available this week, for the August 16th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 225 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of CORT December 21st Options Trading

First Week Of CORT December 21st Options Trading

Investors in Corcept Therapeutics Inc saw new options become available this week, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new December 21st contracts and identified one put and one call contract of particular interest.

First Week Of January 2021 Options Trading For Corcept Therapeutics (CORT)

First Week Of January 2021 Options Trading For Corcept Therapeutics (CORT)

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the January 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 850 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

CORT: Insiders Vs. Shorts

CORT: Insiders Vs. Shorts

The most recent short interest data was recently released for the 07/31/2018 settlement date, and Corcept Therapeutics Inc is one of the most shorted stocks of the Russell 3000, based on 14.78 "days to cover" versus the median component at 5.19. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

First Week Of CORT September 21st Options Trading

First Week Of CORT September 21st Options Trading

Investors in Corcept Therapeutics Inc saw new options become available this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CORT options chain for the new September 21st contracts and identified one put and one call contract of particular interest.

Short Interest In Corcept Therapeutics Expands By 11.5%

Short Interest In Corcept Therapeutics Expands By 11.5%

The most recent short interest data has been released for the 02/28/2018 settlement date, which shows a 1,675,886 share increase in total short interest for Corcept Therapeutics Inc , to 16,292,805, an increase of 11.47% since 02/15/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Target, Triton, Covanta: 'Mad Money' Lightning Round

Target, Triton, Covanta: 'Mad Money' Lightning Round

Jim Cramer highlights Target, Triton, Covanta, and Corcept Therapeutics.

This Is the New, New Normal: Cramer's 'Mad Money' Recap (Wednesday 2/7/18)

This Is the New, New Normal: Cramer's 'Mad Money' Recap (Wednesday 2/7/18)

Jim Cramer says fundamentals of a stock matter less than the mechanics of how this market works. Investors need to be able to handle this kind of volatility.

First Week of CORT August 2018 Options Trading

First Week of CORT August 2018 Options Trading

Investors in Corcept Therapeutics Inc saw new options begin trading this week, for the August 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Corcept, Pure Storage, Nutanix, VMWare: 'Mad Money' Lightning Round

Corcept, Pure Storage, Nutanix, VMWare: 'Mad Money' Lightning Round

Jim Cramer is bullish on Corcept Therapeutics, Pure Storage, Nutanix, VMWare, Tellurian, Switch.

A New and Different Kind of Market: Cramer's 'Mad Money' Recap (Thursday 12/21)

A New and Different Kind of Market: Cramer's 'Mad Money' Recap (Thursday 12/21)

Jim Cramer says there's just not enough stock to meet the demand of the buyers who have had to radically switch their orientation -- thanks to the hot economy and the tax bill.

TheStreet Quant Rating: B (Buy)